Fear of needles is one of health care’s most common, and most ignored, barriers.Millions of people experience anxiety or panic attacks at just the sight of a syringe. Some avoid routine vaccinations or postpone blood tests or IV treatments until sympto…
Author: Healio ophthalmology
FDA approves Yuvezzi eye drop for presbyopia
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics.Yuvezzi (carbachol 2.75%/brimonidine tartrate 0.1% ophthalmic so…
Eye care practitioners urge FDA to approve low-dose atropine
A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the progression of pediatric myopia.It comes after the FDA decided not to approve SYD-101 (0.01% atropine, Sydnexis) in October despite ackno…
IL-6 inhibition promising as pathway for retinal disease therapy
WAIKOLOA, Hawaii — In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the treatment of exudative retinal diseases.Rahimy said that even with the success of anti-VEGF therapies, many patie…
Set boundaries, expectations to prevent ‘mentorship malpractice’
LAS VEGAS — Effective mentorship can accelerate careers, but toxic mentoring behaviors can just as easily derail academic progress if left unchecked, Frank I. Scott, MD, MSCE, warned attendees at Crohn’s & Colitis Congress.“We know that mentorship can …
Federal budget proposal funds NEI, vision injury research
A 2026 budget proposal that retains the National Eye Institute as a stand-alone entity at NIH is advancing through Congress ahead of a Jan. 30 government funding deadline.The proposed HHS budget also revives a vision injury research program defunded la…
FDA clears investigational new drug application for NOV05
The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious anterior uveitis, according to a press release from Novaliq.The randomized, double-masked EYETAC clinical trial will evaluate NOV05 (t…
Sunshine Eye & Retina to feature actionable insights
Sunshine Eye & Retina, formerly known as Telling It Like It Is, will be held from March 26 to 29 at the Fontainebleau Miami Beach.Hosted by Healio LIVE, the meeting will feature new events such as the Corneal Health Roundtable, the Retina Case Conferen…
Pressure adjusting goggles help control nocturnal IOP
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, John P. Berdahl, MD, of Vance Thompson Vision, discusses how to improve nocturnal IOP.{{VIDEO}}Berdahl said there is evidence that elevated IOP at night can lead to glaucoma pr…
RevitalVision improves visual acuity in infantile nystagmus
Patients with infantile nystagmus had significant gains in near and distance visual acuity as well as stereopsis following regular sessions of vision training with RevitalVision software, according to a study.“Visual perceptual learning is a process wh…
OpCT-001 receives orphan drug designation for retinitis pigmentosa
The FDA granted orphan drug designation to OpCT-001 for the treatment of retinitis pigmentosa, according to a press release from BlueRock Therapeutics.The investigational induced pluripotent stem cell-derived cell therapy is currently being evaluated i…
Urcosimod 0.05% granted single-patient use for neuropathic corneal pain
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.The terms of the Investigational New Drug (IND) application stipulate th…
Patient assistance programs yield vision gains
WAIKOLOA, Hawaii — Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs showed sustained vision gains and central subfield thickness reduction.During a presentation at Retina 2026, Mu…
Now that split is final, what if US wants to rejoin WHO?
On Thursday, HHS announced that the United States has completed its withdrawal from WHO.The process began a year ago when President Donald J. Trump, on the night of his inauguration, announced plans to leave WHO, complaining that the agency demanded to…
Listen to patients, determine their needs to choose right IOL
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, Audrey Talley Rostov, MD, of Bellevue Precision Vision, discusses how to choose the right IOL.Rostov said surgeons have a lot of factors to consider, such as the ocular surface…
Medical organizations call for $48.7 billion of NIH funding
More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal year 2026.In a letter sent to the majority and minority leaders of the U.S. House of Representatives and U.S. Senate, 143 medic…
Combining IOL technologies can improve patient satisfaction
WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2026, David F. Chang, MD, of Altos Eye Physicians, discusses how he combines lenses to improve patient satisfaction.Chang said patients often have to choose between good night drivin…
Partnership boosts home-based ocular disease monitoring
A commercial partnership between Topcon Healthcare and RemoniHealth is integrating the latter’s home-based ocular disease monitoring tools with Topcon’s screening technology, according to a press release.“This partnership enables eye care providers to …
AI promising for cataract surgery diagnostics
WAIKOLOA, Hawaii — AI has the potential to transform cataract surgery outcomes for the better, according to a speaker.Surgical planning, predictive analytics for patient recovery and postoperative assessments are a few areas where AI can provide a bene…
Popular chatbots offer medical record integration
Patients will soon have the option to integrate their medical records with popular AI programs, highlighting new dangers along with opportunities to bridge gaps in care, according to experts.OpenAI announced ChatGPT Health — a new experience designed f…